Quick Answer
Mirum Pharmaceuticals, Inc. reported Total Revenue of $521.31 million for fiscal year 2025.
Mirum Pharmaceuticals, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $521.31M | +54.7% |
| 2024 | $336.89M | +80.8% |
| 2023 | $186.37M | +141.8% |
| 2022 | $77.06M | +302.7% |
| 2021 | $19.14M | — |
| 2020 | $0.00 | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $133.01M | +47.2% | +4.1% |
| June 30, 2025 | $127.78M | +64.1% | +14.5% |
| March 31, 2025 | $111.58M | +61.2% | +23.5% |
| September 30, 2024 | $90.38M | +89.4% | +16.1% |
| June 30, 2024 | $77.88M | +107.7% | +12.5% |
| March 31, 2024 | $69.22M | +119.1% | +45.0% |
| September 30, 2023 | $47.73M | +154.1% | +27.3% |
| June 30, 2023 | $37.50M | +114.5% | +18.7% |
- Mirum Pharmaceuticals, Inc. showed an increase of +54.7% in Total Revenue compared to the prior fiscal year.
- The most recent figure is from Mirum Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: